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Background: The aim of this study was to describe the phenomenology of mania and depression in
bipolar patients experiencing a manic episode with mixed features as defined in the new Diagnostic and
Statistical Manual of Mental Disorders (DSM-5).
Methods: In this multicenter, international on-line survey (the IMPACT study), 700 participants
completed a 54-item questionnaire on demographics, diagnosis, symptomatology, communication of
the disease, impact on life, and treatment received. Patients with a manic episode with or without DSM-5
criteria for mixed features were compared using descriptive and inferential statistics.
Results: Patients with more than 3 depressive symptoms were more likely to have had a delay in
diagnosis, more likely to have experienced shorter symptom-free periods, and were characterized by a
marked lower prevalence of typical manic manifestations. All questionnaire items exploring depressive
symptomatology, including the DSM-5 criteria defining a manic episode as “with mixed features”, were
significantly overrepresented in the group of patients with depressive symptoms. Anxiety associated
with irritability/agitation was also more frequent among patients with mixed features.
Limitations: Retrospective cross-sectional design, sensitive to recall bias. Two of the 6 DSM-5 required
criteria for the specifier “with mixed features” were not explored: suicidality and psychomotor
retardation.
Conclusions: Bipolar disorder patients with at least 3 depressive symptoms during a manic episode self-
reported typical symptomatology. Anxiety with irritability/agitation differentiated patients with depressive
symptoms during mania from those with “pure”manic episodes. The results support the use of DSM-5 mixed
features specifier and its value in research and clinical practice.
& 2014 Elsevier B.V.
1. Introduction
Depressive symptomatology concomitant to a manic episode in
bipolar disorder (BD) (also termed mixed, depressive, or dysphoric
mania) constitutes a severe form of the disorder that is commonly
seen in daily practice (Vieta and Valenti, 2013). At the epidemio-
logical and clinical level, compared to pure manic episodes, mania
with concomitant depressive symptoms occurs at a younger age,
and is associated with more frequent episodes of longer duration,
more frequent relapses, lower interepisode intervals, longer time
to achieve symptomatic remission, and higher rates of suicide and
comorbid conditions such as substance abuse (Swann et al., 2013;
Vieta and Valenti, 2013). Moreover, compared with patients with
pure manic episodes, individuals with depressive features have a
poorer response to treatment, a poorer long-term prognosis, more
often require combination therapy, and are at greater risk of
mood-switching following antimanic treatment (Swann et al.,
2013; Vieta and Valenti, 2013).
The diagnosis and classification of mixed manic states is a
matter of debate, and several different criteria have been pro-
posed; some are based on a broad dimensional or intermediate
categorical perspective to better account for the presence of
subsyndromal symptomatology, while others have a more strict
bidimensional approach, as used in official diagnostic classification
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systems such as the Diagnostic and Statistical Manual of Mental
Disorders (DSM), or the Classification of Mental and Behavioral
Disorders (ICD) (Vieta and Valenti, 2013). In the new DSM-5
edition, a mixed-categorical-dimensional definition has been
adopted, and mixed episodes, defined in previous versions as the
co-occurrence of full mania and depression episodes for Z1 week
(American Psychiatric Association, 2000), has been removed.
Instead, a “with mixed features” specifier will now be used for a
manic episode presenting with at least 3 of the following symp-
toms of the opposite polarity: (1) prominent dysphoria or
depressed mood, (2) diminished interest or pleasure in all, or
almost all, activities, (3) psychomotor retardation nearly every day,
(4) fatigue or loss of energy, (5) feelings of worthlessness or
excessive or inappropriate guilt, and (6) recurrent thoughts of
death, recurrent suicidal ideation without a specific plan, or a
suicide attempt or a specific plan for committing suicide.
The assessment and quantification of a possible depressive
component during mania in clinical research will improve accu-
racy of diagnosis and classification, hopefully leading to a better
tailored treatment, better prognosis and improved functioning.
There are several options (not mutually exclusive) to identify the
depressive dimension associated with mania. These include the
use of: (1) classical scales to rate the intensity of the depressive
symptomatology (e.g. the Hamilton Depression Rating Scale, or the
Montgomery-Åsberg Depression Rating Scale), (2) the score in the
number of symptoms present in a checklist of prominent depres-
sive symptoms (e.g. Cincinnati or Vienna criteria) (Akiskal, 1992;
McElroy et al., 1992; Swann et al., 2013), (3) the assessment of the
presence of specific temperament characteristics (e.g. Duke/ROC,
or Pisa-San Diego criteria) (Cassidy et al., 2000; Perugi et al., 1997),
(4) observer-rated scales designed to measure both manic and
depressive symptoms (e.g. the Bipolar Inventory of Symptoms
Scale) (Bowden et al., 2007), and/or (5) self-completed instru-
ments which can also simultaneously capture symptoms of both
polarities (e.g. the Internal State Scale, the Multiple Visual Analog
Scale of Bipolarity, or the Self-Report Manic Inventory)(Azorin and
Hantouche, 2001; Picardi, 2009).
Although the capability of patients with manic symptoms to
make judgments on their symptoms has been questioned, the self-
assessment of mania is reliable and valid even in patients with
psychotic features or limited insight (Altman, 1998). It has also
been demonstrated that patients with manic episodes consistently
report dysphoric symptoms through self-rated depression scales,
with results highly concordant with observer-rated scales (Cassidy
et al., 2009). Most importantly, the differences in self-reported
depressive symptoms can discriminate pure from mixed states in
the acute phase of the illness (Akiskal et al., 1998; Azorin et al.,
2008; Cassidy et al., 2009; Hantouche et al., 2001).
The aim of this study was to describe the specific phenomen-
ology and the frequency of manic and depressive symptoms in
bipolar patients experiencing manic episodes with depressive
features as defined in the new DSM-5. We used a subset of results
specifically related to the presence of depressive symptoms during
a manic phase obtained from a qualitative and quantitative online
survey (IMPACT), designed to retrospectively assess how bipolar
disorder I (BDI) impacts patients0 lives and their priorities for
successful treatment.
2. Methods
2.1. Survey and participants
The study was conducted in Australia, Canada, France,
Germany, Italy, Spain, and the UK between 26th March and 31st
July 2012. An online questionnaire (IMPACT) was used to screen
patients and collect qualitative and quantitative data. Access to the
survey was secure, ensuring the anonymity of the participants.
Individuals were recruited through consumer panels, via psychia-
trists, or patient organizations (Fig. 1). Individuals aged 18–65
years who gave their consent by answering a specific question on
their willingness to participate, were subsequently asked to
complete an online screening form. Participants were eligible if
they were diagnosed with BDI more than 12 months before
participating; had an episode of mania ever that caused significant
distress or greatly impaired their work, family or social life; had an
increase in at least 5 out of 20 statements on affective symptoms
during a period of mania; were in meaningful remission (no
affective symptoms for 3–4 weeks minimum); and were treated
with at least one medication indicated for BDI in the preceding
2 years. A quota sampling procedure was applied, with limits in
the following categories: (1) up to 55% of males or females, (2) up
to 25% of all participants in each age group (18–25, 26–36, 36–45,
46–55, and 56–65 years), (3) a maximum of 25% of all participants
diagnosed between 12 and 24 months before the survey, a
maximum of 35% diagnosed between 2 and 10 years before the
survey, and a maximum of 40% of those diagnosed more than
10 years previously, and (4) a maximum of 50% of participants
with predominant depressive polarity. Eligible participants were
thereafter routed to the second part of the IMPACT questionnaire,
containing sets of questions on demographics (work and marital
status), diagnostic process and time from onset of symptoms to
diagnosis, communicating BD to family and others, impact of the
disease (work life, personal life, relationships, and sleep patterns),
presence of depressive symptoms during a manic phase, periods
of mania and hospitalizations, and the outcome of treatment.
Per country 100 patients participated and all participants fully
completed the questionnaire.
2.2. Questions related to mania and depression
The questionnaire contained 15 questions related to manic
symptoms, 13 related to depressive symptoms, one on anxiety or
worry, and one on irritability or agitation (Supplementary
Material, and Table 2). Seven out of the 13 questions on depressive
symptomatology matched 4 out of the 6 DSM-5 criteria for a manic
episode with mixed features: depressed mood, decreased interest
or pleasure (presence of lack of interest/lethargy and/or decreased
sense of pleasure), feelings of guilt or worthlessness (feelings of
guilt and/or feelings of low self-esteem and/or lack of confidence),
and lack of energy (decrease in energy levels). No data were
obtained for the 2 additional DSM-5 criteria: suicidal thoughts and
psychomotor retardation.
Patients reporting o3 depressive symptoms (the “M w/o DS”
group), were defined as having a pure manic episode; patients
reporting Z3 depressive symptoms (the “Mwith DS” group) were
defined as having a manic episode with mixed features.
2.3. Statistical Analyses
Patients who experienced o3 depressive symptoms (M w/o
DS) were compared with patients who experienced Z3 depres-
sive symptoms (M with DS). This cut-off was chosen for the
current study because it has been previously proposed to be
a practical criterion in the clinical setting to diagnose mixed mania
(McElroy et al., 1992; Swann et al., 2013). Descriptive statistics
comprised the total and frequency of responses. Statistical com-
parisons between the two groups were made using the Chi-square
test. All of the Chi-square statistics used 2 by 2 tables with one
degree of freedom. No correction was applied for multiple testing,
and p values less than 0.05 were considered to be significant.
Odds ratios and 95% confidence intervals (CIs) were calculated as
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a function of the impact of the presence of depressive symptoms
(M with DSM vs. without DS). Results are presented as compar-
isons of the M with DS group vs. the M w/o DS group unless
otherwise specified in the text.
3. Results
3.1. Demographic characteristics
Out of the 56,687 subjects initially screened, 700 subjects (100
per country) completed the IMPACT questionnaire (Fig. 1A). During
a past manic episode, 39% (n¼275) of patients reported Z3 DSM-5
depressive symptoms (Mwith DS), and 61% reported o3 (Mw/o DS)
(n¼425) (Fig. 1B). Differences in age and gender frequency between
groups were not significant. There were more females in the M with
DS group, but this difference was not significant (40% vs. 47%,
p¼0.07). Subjects in the M with DS group were less likely to be
retired than those in the M without DS group (p¼0.02; OR¼0.59,
95% CI¼0.4–0.9); differences regarding relationship status were not
significant.
3.2. Psychiatric history
Patients in the M with DS group were more likely to have been
diagnosed with BDI in recent years (in the last 5 years), and less
likely than those in the M w/o DS group to have been diagnosed
6–10 years ago (19.6% vs. 28.7%; p¼0.007) (Table 1). A diagnosis
more than 10 years ago was equally likely in both groups.
Patients in the M with DS group were more likely to have
depressive symptoms with some manic symptoms at diagnosis
(46.9% vs. 28.9%; po0.001), and were less likely to have experi-
enced only manic symptoms (7.6% vs. 28.2%; po0.0001).
Individuals in the M with DS group were more likely to have
experienced shorter periods free of symptoms (3–4 weeks) than
those in the M w/o DS group (44.7% vs. 20.5%; po0.0001).
3.3. Misdiagnosis before BDI diagnosis
Nearly half of the patients in both groups were initially
diagnosed with another condition: 39% of those in the M with
DS group, and 43% of those in the M w/o DS group (Table 1).
Patients in the M with DS group were significantly more fre-
quently misdiagnosed as having insomnia (46.7% vs. 27.9%;
po0.0001), but were less likely than those in the M w/o DS group
to be misdiagnosed with a major depressive episode (MDE) or
major depressive disorder (MDD) (22.4% vs. 34.4%; p¼0.02).
3.4. Manic symptoms
Out of the 15 manic symptoms assessed, 11 were more likely to
be experienced by patients in the M w/o DS group (Table 2 and
Fig. 1. Description of the IMPACT study methods and sampling for the present study for each country (A), and graphic representation of the distribution of patients according
to the number of depressive features reported during a past manic episode (B).
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Fig. 2), and only physical aggression and abusive behavior towards
others were more frequently reported by individuals in the M with
DS group (35.6% vs. 23.5%, and 41.5% vs. 32.9%, respectively;
p¼0.001 and p¼0.02, respectively).
3.5. Depressive symptoms
Feeling depressed during an episode of mania was reported by
64% of the patients (46.3% in the M w/o DS vs. 94.5% in the M with
DS groups). All of the 13 depressive symptoms assessed were
significantly more represented among the patients in the M with
DS group (Table 2 and Fig. 2B). Depressive symptoms were
grouped to match 4 out of the 6 DSM-5 definitions of mania with
mixed features, and all of them were found to be significantly
overrepresented in the group M with DS (all items po0.001)
(Table 2 and Fig. 2C).
3.6. Anxiety and irritability or agitation
A lower proportion of individuals in the M with DS group
reported feelings of irritability and agitation than of those in the
M w/o DS group (7.6% vs. 38.1%; po0.0001), but they were more
likely to feel anxious or worried (14.2% vs. 6.8%; p¼0.001). More-
over, more patients in the M with DS group had symptoms of
anxiety and irritability associated with agitation (72.4% vs. 27.1%;
po0.0001) (Table 2 and Fig. 2D).
4. Discussion
We performed an online patient survey to describe the phe-
nomenology of a manic episode with mixed features as newly
operationalized in DSM-5. Two-third (64%) of patients reported
feeling depressed when experiencing a manic episode. The self-
reported frequency of Z3 concomitant depressive symptoms
during a manic episode in our study was 39%, which is in accordance
with the overall 31% reported using broader criteria than those of
official classification systems (ICD-10 and DSM-IV-TR) (McElroy et al.,
1992), and close to the 23% prevalence described based on clinician0s
judgment (Vieta and Morralla, 2010).
Patients with DS were more likely than patients without DS to
have been diagnosed less than 5 years ago. This could be related to
the known complex phenomenology that accompanies this dis-
order, which is associated with a delay in its clinical recognition
and classification (Akiskal et al., 1998; Hantouche et al., 2006;
McElroy, 2008). We also recorded a high rate of misdiagnosis
(39% in the case of mania with DS, and 43% in the case of mania
without DS), which are in accordance with previously reported
rates of incorrectly diagnosed BD (Keck et al., 2008; Zimmerman,
2010). Patients without DS were more frequently misdiagnosed as
having a MDE or MDD than those with DS. Patients with mixed
states have been shown to come more frequently from cohorts
with mixed onset, compared to patients with pure mania (Perugi
et al., 2000), highlighting the strong correlation between polarity
onset and predominant polarity during the illness (Baldessarini
et al., 2012; Daban et al., 2006). In line with this, patients with
pure mania may have a more frequent manic onset; however as
manic onset appears to be much less frequent than depressive
onset (Keck et al., 2008; Perugi et al., 2000), it is likely that
patients pure manic symptoms recruited in this study could come
from cohorts with depressive onset. In this regard, it was found in
a recent study, that patients with depressive onset were more
often misdiagnosed as major depressive disorder, compared with
patients with mixed onset (Azorin et al., 2011). Patients with DS
had a 2 fold higher probability of having been diagnosed with
insomnia than patients without DS, a fact that to our knowledge
Table 1
Psychiatric history and illness course of IMPACT study respondents according to the presence of depressive symptoms.
Mania with DS n¼275 Mania w/o DS n¼425 p Valuea Odds ratio (95% CI)
Length of time since diagnosis, n (%)
12–24 months 56 (20.4) 46 (10.8) o0.0001 2.11 (1.38–3.22)
2–5 years 89 (32.4) 106 (24.9) 0.03 1.44 (1.03–2.01)
6–10 years 54 (19.6) 122 (28.7) 0.007 0.61 (0.42–0.87)
11–20 years 51 (18.5) 98 (23.1) NS
21 or more years 25 (9.1) 53 (12.5) NS
Symptoms at diagnosis, n (%)
Manic only 21 (7.6) 120 (28.2) o0.0001 0.21 (0.13–0.34)
Primarily manic, some depressed 88 (32.0) 134 (31.5) NS
Primarily depressed, some manic 129 (46.9) 123 (28.9) o0.0001 2.17 (1.58–2.98)
Depressive only 36 (13.1) 47 (11.1) NS
Longest period without BDI symptoms since diagnosis, n (%)
3–4 weeks 123 (44.7) 87 (20.5) o0.0001 3.14 (2.25–4.39)
5–6 weeks 48 (17.5) 58 (13.6) NS
6 weeks or longer 104 (37.8) 280 (65.9) o0.0001 0.31 (0.23–0.42)
Misdiagnosis, n (%)
Total 107 (38.9) 183 (43.0)
Insomnia 50 (46.7) 51 (27.9) 0.001 2.27 (1.38–3.74)
Major depression or major depressive disorder 24 (22.4) 63 (34.4) 0.02 0.55 (0.33–0.90)
Attention deficit hyperactivity disorder 25 (23.4) 31 (16.9) NS
Psychosis 23 (21.5) 41 (22.4) NS
Schizophrenia 19 (17.8) 22 (12.0) NS
Schizoid personality disorder 16 (15.0) 15 (8.2) NS
Anxiety or generalized anxiety disorder 7 (6.5) 9 (4.9) NS
Borderline personality disorder 5 (4.7) 10 (5.5) NS
Manic depression 3 (2.8) 2 (1.1) NS
Post-partum depression 0 (0.0) 1 (0.5) NS
Obsessive–compulsive disorder 2 (1.9) 2 (1.1) NS
Anorexia 1 (0.9) 2 (1.1) NS
Schizoaffective disorder 0 (0.0) 3 (1.6) NS
NS: non-significant.
a Mania with DS vs. mania w/o DS.
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has not been described before. The results are in agreement with
previous observations of a shorter average total sleep time
associated with severity of mania, and a greater variability in
sleep time associated with a greater severity of both mania and
depressive symptoms (Gruber et al., 2011), which could ultimately
lead to a frequent misdiagnosis of insomnia in patients with DS.
At diagnosis, patients with DS had primarily depressive symp-
toms with some manic symptoms (46.9% M with DS vs. 28.9% M
w/o DS). Most of the patients without DS had a clinical presenta-
tion with only manic symptoms (28.2% M w/o DS vs. 7.6% M with
DS). A substantial proportion of patients in the group without DS
(32%), however, reported primarily manic, but some depressive
symptoms too, which could be explained by a contamination of
this group with subjects having only 1 or 2 DS. This stresses the
need to explore the presence of depressive symptoms in patients
whose initial presentation is apparently “pure manic” (Cassidy and
Carroll, 2001; Cassidy et al., 1998b).
We found that patients with DS self-reported significantly
shorter periods free of symptoms, which is in accordance with
previous studies showing that mixed patients have a lower
proportion of inter-episodic remission (Azorin et al., 2008;
Perugi et al., 1997).
As for the phenomenology of mania, patients with DS were
characterized by a marked lower prevalence of typical manic
manifestations. It is noteworthy the significant lesser over-activity,
euphoria, grandiosity, overly sociability, and decreased need to
sleep. These manic symptoms have been consistently found to be
less represented in patients with mixed features (Cassidy and
Carroll, 2001; Cassidy et al., 1998a, 1998b; Goldberg et al., 2000;
Hantouche et al., 2006), although it has been proposed that, being
relatively infrequent and less evident, they might be of limited
utility when trying to discern a pure manic from mixed episodes
features (Goldberg et al., 2000). Two manic symptoms were found
to be significantly more frequently self-reported by the group with
DS: physical aggression and being abusive towards others. Aggres-
sion is a feature of BD that develops in the context of irritability,
it is reported in subjects during acute episodes or without current
mood symptoms, and has a frequency similar in acute manic and
mixed episodes (Ballester et al., 2012; Latalova, 2009). Trait
aggression is significantly predicted by the presence of a comorbid
borderline personality disorder, and by the severity of current
manic and depressive symptomatology (Garno et al., 2008). It is
not surprising then that the group of patients with DS, who
probably have more severe symptoms and feelings of frustration
and rage, reported higher rates of aggression in our study.
Regarding the phenomenology of depression, we found that
4 out of the 6 new DSM-5 criteria were significantly different
between groups. Although this difference was expected because
patients were grouped based on the number of depressive
symptoms, this preliminarily confirms that a threshold of 3 depres-
sive symptoms has discriminating value, which is in accordance
with previously proposed clinical criteria to identify and diagnose
mixed manic episodes (McElroy et al., 1992; Swann et al., 2013).
Nevertheless, these 3 depressive symptoms are not unique dis-
criminators, as other symptoms were shown to also be able to
differentiate groups. Thus, the presence of other or additional
Table 2
Self-reported symptoms of IMPACT study respondents according to the presence of depressive symptoms.
Mania with DS n¼275 Mania w/o DS n¼425 p Valuea Odds ratio (95% CI)
Manic symptoms, n (%)
Over-activity 179 (65.1) 367 (86.4) o0.0001 0.29 (0.20–0.43)
Excessive behavior 160 (58.2) 303 (71.3) o0.0001 0.56 (0.41–0.77)
Risk taking behavior 137 (49.8) 250 (58.8) 0.02 0.69 (0.41–0.94)
Impulsive behavior 210 (76.4) 344 (80.9) NS 0.76 (0.51–1.10)
Overly sociable 82 (29.8) 259 (60.9) o0.0001 0.27 (0.38–0.53)
Physical aggression 98 (35.6) 100 (23.5) 0.001 1.80 (1.98–2.51)
Abusive towards others 114 (41.5) 140 (32.9) 0.02 1.74 (1.29–1.97)
Promiscuity 55 (20.0) 133 (31.3) 0.001 0.55 (0.38–0.79)
Rapid speech 155 (56.4) 324 (76.2) o0.0001 0.40 (0.38–0.56)
Talking too much 158 (57.5) 326 (76.7) o0.0001 0.41 (0.29–0.57)
Racing thoughts 224 (81.5) 369 (86.8) NS 0.67 (0.29–1.1)
Feeling happy/euphoric 122 (44.0) 360 (84.7) o0.0001 0.14 (0.2–0.4)
Feelings of superiority 78 (28.4) 277 (65.2) NS 0.21 (0.29–1.46)
Feeling sexual 63 (22.9) 201 (47.3) o0.0001 0.33 (0.15–0.46)
Not feeling the need to sleep 145 (52.7) 347 (81.6) o0.0001 0.25 (0.18–0.35)
Depressive symptoms, n (%)
(DSM-5 mixed features specifier)
Depressed mood 260 (94.5) 188 (46.3) o0.0001 20.09 (11.53–35.04)
Decreased interest/pleasure
Lack of interest/lethargy 187 (68.0) 17 (4.0) o0.0001 51.0 (29.50–88.16)
Decreased sense of pleasure 178 (64.7) 66 (15.5) o0.0001 9.98 (6.96–14.32)
Feelings of guilt/worthlessness
Feelings of guilt 156 (56.7) 50 (11.8) o0.0001 9.83 (6.73–14.37)
Feelings of low self-esteem 196 (71.3) 41 (9.6) o0.001 23.24 (15.35–31.18)
Lack of confidence 196 (71.3) 22 (5.2) o0.0001 45.45 (27.50–75.11)
Lack of energy
Decrease in energy levels 194 (70.5) 21 (4.9) o0.0001 46.08 (27.68–76.70)
Other symptoms, n (%)
Not wanting to socialize 171 (62.2) 53 (12.5) o0.0001 11.5 (7.91–16.82)
Low sex drive 125 (45.5) 23 (5.4) o0.0001 14.56 (8.99–23.60)
More need for sleep than usual 127 (46.2) 27 (6.4) o0.0001 12.65 (8.01–19.96)
Difficulty focusing 227 (82.5) 320 (75.3) 0.02 1.55 (1.06–2.27)
Not remembering things 168 (61.1) 202 (47.5) o0.0001 1.73 (1.27–2.36)
Difficulty making decisions 178 (64.7) 171 (40.2) o0.0001 2.73 (1.99–3.73)
Feeling anxious or worried only 39 (14.2) 29 (6.8) 0.001 2.26 (1.36–3.75)
Feeling irritable or agitated only 21 (7.6) 162 (38.1) o0.0001 0.13 (0.08–0.22)
Feeling anxious or worried and irritable or agitated 199 (72.4) 115 (27.1) o0.0001 7.06 (5.02–9.92)
a Comparison of Mania with DS vs. mania w/o DS patients.
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depressive symptoms could also be of clinical value when attempt-
ing to differentiate pure from manic episodes with mixed features.
Depressed mood, anxiety, excessive guilt, and increased suicid-
ality have been identified as core depressive symptoms in the
context of mixed states in factor and cluster analyses (Akiskal
et al., 1998; Cassidy and Carroll, 2001; Cassidy et al., 1998a, 1998b).
In the present study, both depressed mood and feelings of guilt
were found to be able to differentiate between the two groups of
patients, but the presence of suicidal thoughts and behaviors,
which is also one of the required criteria of DSM-5, was not
assessed in the survey. In fact, DSM-5 differentiates between two
new specifiers: the mixed features specifier, as analyzed in this
study, and the suicidal risk specifier, which should be assessed
separately. The IMPACT survey also assessed non-mood symptoms,
including anxiety, agitation, and irritability, which are prominent
components of mixed manic states (Vieta and Valenti, 2013).
Factor analyses on the symptom structure of mania have consis-
tently found that anxiety has strong positive loading on the
depression factor (Cassidy, 2010). Moreover, anxiety correlates
with the presence and severity of depressive symptoms in patients
with mixed mania (Azorin et al., 2009; Swann et al., 2009) and is
associated with poor outcome (Gonzalez-Pinto et al., 2012). This is
in accordance with the results of the present study, where the
frequency of anxiety was higher among patients with DS, and with
the suggestion made by others that it should be considered a
specific symptom (excluded from the DSM-5 needed depressive
features) that is also able to discriminate between the two states
(Cassidy, 2010; Pacchiarotti et al., 2013). Irritability has also been
consistently identified as being part of the symptom structure of
mixed mania (Swann et al., 2013), and reported to be more prevalent
among patients with more than 2 or 3 depressive symptoms (Cassidy
et al., 1998a; Goldberg et al., 2000; Hantouche et al., 2006). Although
feelings of only agitation or irritability were more common among
patients without DS in our cohort, the presence of both anxiety and
irritability or agitation was 5–9 folds more probable to be self-
reported by patients with DS. The combination of anxiety and
irritability or agitation during a manic episode could be used as a
relevant discriminator for the presence of depressive symptoms.
Finally, one interesting finding in the IMPACT study is that
patients with DS significantly reported having more difficulty
remembering things, focusing, and making decisions than patients
without DS. Although differences in neuropsychological deficits
between patients with pure manic symptoms and patients with
depressive symptoms have rarely been explored, patients with
mixed episodes as defined by DSM-III-R criteria were reported to
perform more poorly in overall attention tasks than patients with
pure manic episodes (Sax et al., 1995), and subthreshold depres-
sive symptoms have been reported to influence neurocognitive
performance (Bonnin et al., 2012). There are a number of strengths
and limitations to the study. A strength is that the participants in
the survey may be representative of the overall BDI population, as
they were selected to match similar demographic characteristics
and were not obtained from tertiary centers, as in many other
studies (Vieta, 2013). Besides, the study obtained a large sample
size of patients that were engaged across seven different countries,
which probably allows extrapolation of the results within a larger
framework of countries. Nevertheless, we do acknowledge a
possible sample bias, as the online survey was based on a
voluntary response, and there is no information on the clinical
profile of those who refused to participate. Moreover, the study
was based on a retrospective cross-sectional design and subject to
recall bias, and warrants a longitudinal validation. Finally, the
respondents are limited to a population of euthymic outpatients,
which might also have biased the sample by excluding subjects
Fig. 2. Frequency of respondents (n¼700) who, during a past manic episode, self-reported manic symptoms (A), depressive symptoms (B), depressive symptoms as defined
by the “mixed features specifier” in DSM-5 (C), and symptoms of anxiety or irritability associated with agitation (D). nPo0.05 Mania with DS versus Mania w/o DS;
nnPo0.001 Mania with DS versus Mania w/o DS; †Po0.0001 Mania with DS versus Mania w/o DS.
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with more severe affective symptomatology. However, our results
in general are in agreement with other community surveys that
enrolled patients during the acute phase (Akiskal et al., 1998;
Azorin et al., 2008; Hantouche et al., 2006, 2001), and with the
only one that included both inpatients and outpatients (Azorin
et al., 2009). Moreover, it has been reported that the concordance
between observer vs. self-rated scales increases with the patient0s
symptomatological improvement (Moller, 2000). Thus, the fact
that our population self-reported their symptoms during euthymia
might have not negatively impacted the results. Our results are
also concordant with surveys that used exclusively self-rated
scales (Hantouche et al., 2001), or a combination of clinician and
self-reported instruments (Akiskal et al., 1998; Azorin et al., 2008;
Hantouche et al., 2006, 2001).
The findings of the IMPACT survey show that the self-rated
retrospective assessment of symptoms during mania is feasible,
and could be a helpful for clinicians to assess mixicity. Actually,
both prospective and retrospective self-ratings to dimensionally
assess mania and depression have shown its reliability and
validity, and are being used in naturalistic studies such as the
Stanley Foundation Bipolar Network (Post et al., 2001) and the
WAVE-bd study (Vieta et al., 2013). Finally, the results of the
survey preliminarily show that a threshold of 3 depressive symp-
toms during a manic episode as operationalized in the new DSM-5
can be used to identify mixed vs. non-mixed patients. The
3-symptom threshold should now be also validated for depressive
episodes with mixed features, as proposed in DSM-5.
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